Skip to main content

. 1973 Dec;66(12):1240–1242. doi: 10.1177/003591577306601240

Evolution of a practical policy for chemotherapy of carcinoma of the breast.

PMCID: PMC1645336 PMID: 4777061

1240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Ansfield F. J., Ramirez G., Korbitz B. C., Davis H. L., Jr Five-drug therapy for advanced breast cancer: a phase I study. Cancer Chemother Rep. 1971 Apr;55(2):183–187. [PubMed] [Google Scholar]
Bagshawe K. D. Tumour growth and anti-mitotic action. The role of spontaneous cell losses. Br J Cancer. 1968 Dec;22(4):698–713. doi: 10.1038/bjc.1968.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
Bruce W. R., Meeker B. E., Valeriote F. A. Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst. 1966 Aug;37(2):233–245. [PubMed] [Google Scholar]
Costanzi J. J., Coltman C. A., Jr Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors. Cancer. 1969 Mar;23(3):589–596. doi: 10.1002/1097-0142(196903)23:3<589::aid-cncr2820230310>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
Frei E., 3rd Combination cancer therapy: Presidential address. Cancer Res. 1972 Dec;32(12):2593–2607. [PubMed] [Google Scholar]
Hanham I. W., Newton K. A., Westbury G. Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime. Br J Cancer. 1971 Sep;25(3):462–478. doi: 10.1038/bjc.1971.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
SKIPPER H. E., SCHABEL F. M., Jr, WILCOX W. S. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIV. FURTHER STUDY OF CERTAIN BASIC CONCEPTS UNDERLYING CHEMOTHERAPY OF LEUKEMIA. Cancer Chemother Rep. 1965 Apr;45:5–28. [PubMed] [Google Scholar]

ACTIONS

RESOURCES